Introduction
This essay identifies two core ethical principles, autonomy and non-maleficence, in the context of medicines management. It critically examines how these principles support safe medicines administration within nursing practice. The discussion draws on professional standards and established bioethical frameworks to illustrate their application and limitations in contemporary UK healthcare settings.
Autonomy and Patient-Centred Medicines Management
Autonomy refers to the respect for a patient’s right to self-determination regarding their treatment choices. In medicines management, this principle requires nurses to ensure that patients receive sufficient information to provide informed consent before medication administration. The Nursing and Midwifery Council (2018) emphasises the duty to respect patient autonomy by involving individuals in decisions about their medicines. However, practical constraints such as time pressures or impaired capacity can limit the extent to which autonomy is fully realised. For example, when administering controlled drugs, nurses must balance the obligation to inform patients against the need to maintain safety protocols, sometimes resulting in curtailed discussions that arguably undermine genuine choice.
Non-Maleficence and Error Prevention
Non-maleficence, the obligation to avoid causing harm, directly informs safe administration practices. Nurses apply this principle by adhering to the “five rights” of medication administration and conducting thorough checks to prevent adverse events. Beauchamp and Childress (2019) highlight that non-maleficence extends beyond intentional harm to include the prevention of foreseeable risks. In practice, this underpins double-checking procedures and incident reporting systems required by NHS organisations. Nevertheless, systemic factors such as staffing shortages may compromise these safeguards, revealing that non-maleficence cannot be upheld solely through individual nurse vigilance but also requires organisational support.
Interrelationship and Limitations in Practice
While autonomy and non-maleficence are complementary, tensions can arise. A patient’s autonomous refusal of essential medication may conflict with the nurse’s duty to prevent harm. In such situations, nurses must navigate legal frameworks such as the Mental Capacity Act 2005 to determine capacity, thereby ensuring decisions remain ethically defensible. Critical analysis suggests that overemphasis on one principle at the expense of the other risks either paternalism or preventable harm. Therefore, effective medicines management requires a nuanced, context-specific application of both principles alongside ongoing professional reflection.
Conclusion
Autonomy and non-maleficence provide essential ethical foundations for safe medicines management and administration. Their application supports informed patient involvement while prioritising harm prevention, yet real-world constraints highlight the need for systemic as well as individual accountability. Nurses who integrate these principles with professional guidance can better deliver person-centred, safe care, though continued education and adequate resources remain necessary to resolve inherent conflicts.
References
- Beauchamp, T.L. and Childress, J.F. (2019) Principles of Biomedical Ethics. 8th edn. Oxford: Oxford University Press.
- Nursing and Midwifery Council (2018) The Code: Professional Standards of Practice and Behaviour for Nurses, Midwives and Nursing Associates. London: Nursing and Midwifery Council.
